Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia. The order is comprised of a variety of Varian linear accelerators and software including Halcyon(TM), TrueBeam(R), and HyperArc(TM). These systems will be installed in new and existing Icon cancer centers in Australia to increase capacity and broaden patient access, as well as in cancer centers in Singapore and China. "We are extremely proud of our global partnership with Varian, which continues to help meet our long-term goal of increasing access to care. This investment helps to address the cancer burden in rural and regional Australia and underserved communities in Singapore and China," said Mark Middleton, CEO of Icon Group. "It's great to see progress being made on the path to a world where cancer is no longer a burden; where people have every opportunity to fight cancer no matter where they live." Icon continues to play a paramount role in the development of radiation oncology treatments and has been an early adopter of Varian technologies over the years, including the first in Australasia to install the Varian Halcyon radiotherapy system and first in Australia to install and treat with HyperArc technology – benefitting patients with multiple tumors in the brain. Icon Group is also a member of the Varian Adaptive Intelligence(TM) Consortium, alongside other international institutions, to collaboratively develop clinical and technical aspects of Ethos(TM) therapy and wider radiation therapy treatments and techniques that will continue to evolve cancer care. "We are honored to be selected once again by Icon Group to provide Varian radiotherapy and radiosurgery systems for its cancer centers around the world," said Chris Toth, CEO, Varian, a Siemens Healthineers company. "As the cancer burden continues to rise, we are proud to work with our global partners at Icon Group to expand access to advanced cancer care to achieve a world without fear of cancer." About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 11,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter. Press Contact Lynne Tran Corporate Communications publicrelations@varian.com Investor Relations Contact Siemens Healthineers Investor Relations [ https://c212.net/c/link/?t=0&l=en&o=3142464-1&h=1186246278&u=https%3A%2F%2Fwww.corporate.siemens-healthineers.com%2Finvestor-relations%2Fcontact&a=Siemens+Healthineers+Investor+Relations ] SOURCE Varian